Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sugammadex Titration for Reversal of Rocuronium or Vecuronium in Cardiac Surgery Patients

NCT05246397 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT05246397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05246397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sugammadex Titration for Reversal of Rocuronium or Vecuronium in Cardiac Surgery Patients
Lead sponsor
University of Washington
Phase
Phase 4
Overall status
Completed
Start date
February 1, 2022
Completion date
November 10, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aorta disease, coronary artery disease, heart failure, valvular heart disease